Glutamine supplementation alleviated aortic atherosclerosis in mice model and in vitro
PROTEOMICS · 2024
DOI: 10.1002/pmic.202300179 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS, 2024. Verfasst von Hao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, National Clinical Research Centre for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Glutamine, Atherosclerosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Clinical Research Centre for Geriatric Diseases.
Abstract (Originalsprache)
This study aimed to clarify the role of glutamine in atherosclerosis and its participating mechanism. Forty C57BL/6J mice were divided into wild control (wild Con), ApoE − / − control (ApoE − / − Con), glutamine + ApoE − / − control (Glut + ApoE − / − Con), ApoE − / − high fat diet (ApoE − / − HFD), and glutamine + ApoE − / − HFD (Glut + ApoE − / − HFD) groups. The degree of atherosclerosis, western blotting, and multiomics were detected at 18 weeks. An in vitro study was also performed. Glutamine treatment significantly decreased the degree of aortic atherosclerosis ( p = 0.03). O ‐GlcNAcylation ( O ‐GlcNAc), IL‐1β, IL‐1α, and pyruvate kinase M2 (PKM2) in the ApoE − / − HFD group were significantly higher than those in the ApoE − / − Con group ( p < 0.05). These differences were attenuated by glutamine treatment ( p < 0.05), and aggravated by O ‐GlcNA transferase (OGT) overexpression in the in vitro study ( p < 0.05). Multiomics showed that the ApoE − / − HFD group had higher levels of oxidative stress regulatory molecules (guanine deaminase [GUAD], xanthine dehydrogenase [XDH]), proinflammatory regulatory molecules (myristic acid and myristoleic acid), and stress granules regulatory molecules (caprin‐1 and deoxyribose‐phosphate aldolase [DERA]) ( p < 0.05). These differences were attenuated by glutamine treatment ( p < 0.05). We conclude that glutamine supplementation might alleviate atherosclerosis through downregulation of O ‐GlcNAc, glycolysis, oxidative stress, and proinflammatory pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, National Clinical Research Centre for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Department of Evidence-Based Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Surgical Laboratory, Xuanwu Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Jinggang Xia
Förderung
- National Clinical Research Centre for Geriatric Diseases
Zitieren
APA
Zhang, H., Wang, C., Sun, H., Zhou, T., Ma, C., Han, X., Zhang, T., & Xia, J. (2024). Glutamine supplementation alleviated aortic atherosclerosis in mice model and in vitro. PROTEOMICS. https://doi.org/10.1002/pmic.202300179
Vancouver
Zhang H, Wang C, Sun H, Zhou T, Ma C, Han X, et al. Glutamine supplementation alleviated aortic atherosclerosis in mice model and in vitro. PROTEOMICS. 2024. doi:10.1002/pmic.202300179
BibTeX
@article{Zhang2024,
author = {Zhang, Hao and Wang, Chunxiu and Sun, Haichen and Zhou, Tian and Ma, Chang and Han, Xuexue and Zhang, Tianxing and Xia, Jinggang},
title = {Glutamine supplementation alleviated aortic atherosclerosis in mice model and in vitro},
journal = {PROTEOMICS},
year = {2024},
doi = {10.1002/pmic.202300179}
}
EUVIMED